CRISPR Therapeutics AG (CRSP) Intangibles (2015 - 2024)
CRISPR Therapeutics AG's (CRSP) quarterly Intangibles came in at $2000.0 in Q1 2024, down 96.49% year-on-year from $57000.0 in Q2 2023, and down 87.5% quarter-over-quarter from $16000.0 in Q4 2023.
CRISPR Therapeutics AG (CRSP) Intangibles (2015 - 2024) Analysis & Trends
CRISPR Therapeutics AG has disclosed Intangibles across 10 years of filings, most recently posting $2000.0 for Q1 2024.
- Intangibles for Q1 2024 came in at $2000.0, down 96.49% year-over-year; the trailing twelve-month figure through Mar 2024 was $2000.0 (down 96.49% YoY), and the FY2023 annual result was $16000.0, down 77.46% from the prior year.
- Intangibles came in at $2000.0 for Q1 2024 at CRISPR Therapeutics AG, down from $16000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $221000.0 in Q1 2020 to a low of $2000.0 in Q1 2024.
- The 5-year median for Intangibles is $112000.0 (2022), against an average of $111764.7.
- Across the five-year window, Intangibles decreased 19.93% in 2020 and sank 96.49% in 2024, its largest moves.
- CRISPR Therapeutics AG's Intangibles stood at $180000.0 in 2020, then slumped by 30.56% to $125000.0 in 2021, then tumbled by 43.2% to $71000.0 in 2022, then slumped by 77.46% to $16000.0 in 2023, then tumbled by 87.5% to $2000.0 in 2024.
- The last three Intangibles figures came in at $2000.0 (Q1 2024), $16000.0 (Q4 2023), and $30000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | CRISPR Therapeutics AG | 5.21 Bn | 2.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Dec 31, 2020 | 180,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | 208,000.00 |
| Mar 31, 2020 | 221,000.00 |
| Dec 31, 2019 | 235,000.00 |
| Sep 30, 2019 | 249,000.00 |
| Jun 30, 2019 | 262,000.00 |